| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |